Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis

Published:2015-12-10 Issue:1 Volume:3 Page:e183
ISSN:2332-7812
Container-title:Neurology - Neuroimmunology Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Gross Catharina C.,Schulte-Mecklenbeck Andreas,Klinsing Svenja,Posevitz-Fejfár Anita,Wiendl Heinz,Klotz Luisa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Neurology

Reference37 articles.

1. Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

2. A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

3. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

4. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration

5. Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Characterization of the Th1/Th2 Ratio in Multiple Sclerosis Patients and its Response to a Dietary Supplement Regimen;Journal of Dietary Supplements;2024-08-14

2. Metabolic Adaptations and Functional Activity of Macrophages in Homeostasis and Inflammation;Biochemistry (Moscow);2024-05

3. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice;International Immunopharmacology;2023-12

4. Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity;Multiple Sclerosis and Related Disorders;2023-12

5. Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation;Cytotherapy;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3